Loading...

MMNP

P

IMMUNOPRECISE ANTIBODIES LTD

(IPA)

2025 6-K

Show Summary

Summary

Filing Notification

3 Sep '25

Company Update

2 Sep '25

Filing Announcement

27 Aug '25

Filing Update

6 Aug '25

Event Filing Notice

1 Aug '25

Earnings Release

29 Jul '25

Filing Notification

24 Jul '25

Filing Update

21 Jul '25

Filing Announcement

14 Jul '25

Filing Announcement

7 Jul '25

Filing Announcement

3 Jul '25

Filing Announcement

24 Jun '25

Filing Announcement

12 Jun '25

Filing Notification

5 Jun '25

Filing Details

21 May '25

Filing Announcement

12 May '25

Filing Announcement

11 Apr '25

April Filing Update

9 Apr '25

Earnings Release

28 Mar '25

Financial Update

28 Mar '25

Filing Confirmation

13 Mar '25

Filing Report

12 Mar '25

Filing Report

24 Feb '25

Filing Amendment

3 Feb '25

6-K Filing Update

27 Jan '25

Filing Notification

22 Jan '25

Filing Update

17 Jan '25

Form 6-K Filing

3 Jan '25

6-K Filing Summary

23 Dec '24

Q2 Earnings Filing

10 Dec '24

Earnings Release

10 Dec '24

Earnings Release

3 Dec '24

Voting Results Report

15 Nov '24

Filing Update

13 Nov '24

Filing Status Update

4 Nov '24

Filing Announcement

28 Oct '24

Annual Shareholder Meeting

23 Oct '24

Press Release Filing

21 Oct '24

Annual Meeting Notice

11 Oct '24

Filing Report

10 Oct '24

Filing Confirmation

2 Oct '24

Filing Announcement

26 Sep '24

Filing Update

23 Sep '24

Filing Report

17 Sep '24

Filing Amendment

16 Sep '24

Financial Results Report

16 Sep '24

Earnings Release

16 Sep '24

Filing Announcement

9 Sep '24

Company Filing Update

26 Aug '24

ImmunoPrecise Filing

23 Aug '24

Filing Notification

19 Aug '24

Company Filing Update

29 Jul '24

Filing Reported

23 Jul '24

Filing Report

16 Jul '24

Filing Notification

15 Jul '24

Filing Report

27 Jun '24

Filing Date Confirmed

25 Jun '24

Filing Summary

12 Jun '24

Filing Overview

10 Jun '24

6-K Filing Summary

4 Jun '24

Filing Summary

28 Mar '24

Filing Notification

20 Mar '24

Filing Notice

14 Mar '24

Financial Report Summary

14 Mar '24

AI Model Development

7 Mar '24

Sales Agreement

23 Feb '24

Financial Update Filing

15 Feb '24

External Links:

SEC

ImmunoPrecise Antibodies Ltd. submitted a 6-K report on June 12, 2025, indicating it filed under Rule 13a-16 of the Securities Exchange Act and will report with Form 20-F. This filing is considered significant for investors, reflecting company's regulatory compliance and operational updates.

AI Assistant

IMMUNOPRECISE ANTIBODIES LTD

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.